Cocciolillo, Fabrizio
 Distribuzione geografica
Continente #
EU - Europa 1.069
NA - Nord America 898
AS - Asia 224
OC - Oceania 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.197
Nazione #
US - Stati Uniti d'America 893
DE - Germania 377
IT - Italia 195
SE - Svezia 170
CN - Cina 159
UA - Ucraina 98
FR - Francia 59
GB - Regno Unito 56
IE - Irlanda 39
IN - India 25
FI - Finlandia 23
RU - Federazione Russa 23
SG - Singapore 21
BE - Belgio 13
TR - Turchia 9
CA - Canada 5
GR - Grecia 4
JP - Giappone 4
AU - Australia 3
CH - Svizzera 3
HK - Hong Kong 3
AT - Austria 2
CL - Cile 2
HU - Ungheria 2
AE - Emirati Arabi Uniti 1
ES - Italia 1
EU - Europa 1
GE - Georgia 1
IR - Iran 1
MD - Moldavia 1
NL - Olanda 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.197
Città #
Chandler 212
Ashburn 58
Jacksonville 56
Nanjing 44
San Mateo 43
Dublin 39
Wilmington 28
Ann Arbor 27
Boston 23
Bremen 23
Dearborn 23
Nürnberg 22
Cattolica 21
Chicago 21
Munich 20
Milan 19
Lawrence 17
Houston 16
Lancaster 16
Marseille 15
Nanchang 15
Seattle 14
Beijing 13
Brussels 11
Hangzhou 11
Redwood City 11
Rome 11
Singapore 11
Woodbridge 11
Izmir 9
Moscow 9
Shenyang 9
Columbus 8
Falls Church 8
New York 8
Norwalk 8
Zhengzhou 8
Fairfield 7
Mountain View 7
Tianjin 7
Guangzhou 6
Hebei 6
Princeton 6
Renton 6
Augusta 5
Jiaxing 5
Swansea 5
Arezzo 4
Battipaglia 4
Helsinki 4
Kunming 4
Tredegar 4
Cardiff 3
Hefei 3
Jinan 3
Lanzhou 3
Leawood 3
Ottawa 3
Pune 3
Turin 3
University Park 3
Andover 2
Berlin 2
Boardman 2
Brisbane 2
Budapest 2
Cambridge 2
Civitella in Val di Chiana 2
Ercolano 2
Fremont 2
Fuzhou 2
Hong Kong 2
Marano Di Napoli 2
Napoli 2
Palermo 2
Paris 2
Sant'Andrea Bagni 2
Sassari 2
Villeurbanne 2
Zurich 2
Amsterdam 1
Athens 1
Athína 1
Aversa 1
Box Hill 1
Bratislava 1
Busto Arsizio 1
Casoria 1
Castelbellino 1
Central 1
Chisinau 1
Dubai 1
Edinburgh 1
Gent 1
Gurgaon 1
Herndon 1
Huzhou 1
Indiana 1
Kazan 1
Kish 1
Totale 1.083
Nome #
Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report 156
Difference in striatal dopamine transporter availability and psychiatric symptoms in Parkinson's disease subtypes: 123I-FP-CIT SPECT results 150
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose. 135
Dopamine transporter availability in gambling disorder: preliminary 123I-FP-CIT SPECT results 133
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 132
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 123
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 121
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose 109
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 106
Atypical presentation of plasma cell leukemia secondary to multiple myeloma detected by F-18 FDG PET/CT 102
Changes of Dopamine Transporter Availability in Depressed Patients with and without Anhedonia: A 123I-N-ω-Fluoropropyl-Carbomethoxy-3β-(4-Iodophenyl)tropane SPECT Study 101
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 90
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al. 86
Diagnostic performance of (18)F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis 81
Detection Rate of Recurrent Medullary Thyroid Carcinoma Using Fluorine-18 Dihydroxyphenylalanine Positron Emission Tomography: A Meta-analysis 75
The Contursi Family 20 Years Later: Intrafamilial Phenotypic Variability of the SNCA p.A53T Mutation 73
MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis. 70
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT study: reply to comment by Erro et al. 68
Imaging studies on dopamine transporter and depression: A review of literature and suggestions for future research. 68
Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis. 66
Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report 64
Predicting progression of amnesic MCI: The integration of episodic memory impairment with perfusion SPECT 58
Predicting progression of amnesic MCI: The integration of episodic memory impairment with perfusion SPECT 51
Totale 2.218
Categoria #
all - tutte 6.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.841


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020301 63 13 13 11 16 29 36 8 20 22 48 22
2020/2021199 3 21 2 20 25 14 24 3 25 19 40 3
2021/2022274 18 21 7 16 24 14 7 35 18 11 37 66
2022/2023578 86 83 39 108 31 58 20 41 59 21 19 13
2023/2024203 25 65 6 9 6 22 7 18 0 2 21 22
Totale 2.218